vendredi 25 mars 2022

F.D.A.’s Accelerated Drug Approvals Come Under Scrutiny

A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work.

from NYT > Health https://ift.tt/L6gaFmu
via health&fitness

Aucun commentaire:

Enregistrer un commentaire